CoChat
Sign Up
Cited by 270

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Nonalcoholic fatty liver disease and aging: epidemiology to management.

Bertolotti, Marco·2014·World Journal of Gastroenterology
DOI 10.3748/wjg.v20.i39.14185
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3748/wjg.v20.i39.14185

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Liver adiposity and fibrosis are known to increase with age and to be influenced by blood heterochronicity.

    “Liver adiposity and fibrosis are known to increase with age and to be influenced by blood heterochronicity [1, 9, 14, 35–38].”

    From Rejuvenation of three germ layers tissues by exchanging old blood plasma with saline-albumin (2020) · cites this paper as [35]

    Table 1 (page unavailable) reports increased liver fibrosis with aging, but also a reduced percentage of fat on liver biopsy, rather than increased liver adiposity. The Background says NAFLD mainly affects middle-aged and elderly people. No passage in our copy links either liver change to blood heterochronicity (searched: heterochronicity, heterochronic parabiosis, young blood). (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 222

  1. 10.1016/j.arr.2012.02.007 · DOI
  2. 10.1159/000235677 · DOI
  3. 10.1002/ar.22504 · DOI
  4. Jin J, Wang GL, Timchenko L, Timchenko NA. GSK3beta and aging liver. Aging (Albany NY) 2009;1:582-585. · DOI
  5. 10.1093/gerona/glr094 · DOI
  6. 10.1038/nm.1851 · DOI · Paper page
  7. 10.1126/science.1208607 · DOI
  8. 10.1016/j.alcohol.2010.07.004 · DOI
  9. Lonardo A, Sookoian S, Chonchol M, Loria P, Targher G. Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD. Curr Pharm Des 2013;19:5177-5192. · DOI
  10. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007;25:883-889. · DOI
  11. 10.1055/s-0032-1329905 · DOI
  12. 10.1016/j.jadohealth.2012.01.010 · DOI
  13. Lonardo A, Carani C, Carulli N, Loria P. ‘Endocrine NAFLD’ a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. J Hepatol 2006;44:1196-1207. · DOI
  14. 10.1016/j.jhep.2012.07.028 · DOI
  15. 10.1016/j.exger.2013.05.059 · DOI
  16. 10.1016/j.jhep.2013.05.044 · DOI
  17. 10.1016/j.jhep.2012.11.021 · DOI
  18. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med 1988;27:142-149. · DOI
  19. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 2003;38:954-961. · DOI
  20. Shen L, Fan JG, Shao Y, Zeng MD, Wang JR, Luo GH, Li JQ, Chen SY. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol 2003;9:1106-1110. · DOI
  21. Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, Li F, Chen SY. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005;43:508-514. · DOI
  22. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, Yueh SK. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol 2006;40:745-752. · DOI
  23. Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, Sung IK, Sohn CI, Keum DK, Kim BI. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006;21:138-143. · DOI
  24. Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int 2006;26:856-863. · DOI
  25. Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, Shi SL, Chen MH, Hu PJ. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol 2007;13:6419-6424. · DOI
  26. Lee JY, Kim KM, Lee SG, Yu E, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center. J Hepatol 2007;47:239-244. · DOI
  27. Miyaaki H, Ichikawa T, Nakao K, Yatsuhashi H, Furukawa R, Ohba K, Omagari K, Kusumoto Y, Yanagi K, Inoue O. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis. Liver Int 2008;28:519-524. · DOI
  28. 10.1186/1471-230X-12-123 · DOI
  29. 10.1136/gutjnl-2011-300342 · DOI
  30. 10.3748/wjg.v18.i3.237 · DOI
  31. 10.1007/s00535-012-0533-z · DOI
  32. 10.5144/0256-4947.2012.288 · DOI
  33. 10.1007/s10620-013-2652-7 · DOI
  34. 10.1038/ajg.2013.104 · DOI
  35. 10.1111/jgh.12290 · DOI
  36. Lonardo A, Lombardini S, Scaglioni F, Ballestri S, Verrone AM, Bertolotti M, Carulli L, Ganazzi D, Carulli N, Loria P. Fatty liver, carotid disease and gallstones: a study of age-related associations. World J Gastroenterol 2006;12:5826-5833. · DOI
  37. Bedogni G, Miglioli L, Masutti F, Castiglione A, Crocè LS, Tiribelli C, Bellentani S. Incidence and natural course of fatty liver in the general population: the Dionysos study. Hepatology 2007;46:1387-1391. · DOI
  38. 10.1097/MEG.0b013e32832fcdf0 · DOI
  39. 10.1007/s00592-012-0406-1 · DOI
  40. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004;40:1387-1395. · DOI · Paper page
  41. 10.1097/MD.0b013e3182779d49 · DOI
  42. 10.1002/hep.24726 · DOI
  43. 10.1097/MEG.0b013e32834a94fb · DOI
  44. Nakajima T, Nakashima T, Yamaoka J, Shibuya A, Itoh Y, Yoshikawa T. Age is a negative, and visceral fat accumulation is a positive, contributor to hepatic steatosis, regardless of the fibrosis progression in Non-alcoholic Fatty Liver Disease. J Gastroenterol Hepatol Res 2012;1:315-319.
  45. Carulli L, Lonardo A, Lombardini S, Marchesini G, Loria P. Gender, fatty liver and GGT. Hepatology 2006;44:278-279. · DOI
  46. 10.1002/hep.26072 · DOI
  47. 10.1111/j.1478-3231.2004.0969.x · DOI
  48. 10.1002/hep.26465 · DOI
  49. Suzuki A, Diehl AM. Should nonalcoholic fatty liver disease be treated differently in elderly patients? Nat Clin Pract Gastroenterol Hepatol 2005;2:208-209. · DOI
  50. 10.3109/07853890.2010.518623 · DOI
  51. 10.1038/nrgastro.2013.41 · DOI · Paper page
  52. 10.1111/j.1572-0241.2008.02034.x · DOI
  53. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-438. · DOI · Paper page
  54. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664-669. · DOI
  55. Caldwell SH, Crespo DM. The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J Hepatol 2004;40:578-584.
  56. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, Musso A, De Paolis P, Capussotti L, Salizzoni M. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-140. · DOI
  57. Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80. · DOI · Paper page
  58. 10.1002/hep.23594 · DOI
  59. 10.1111/j.1872-034X.2012.01031.x · DOI
  60. 10.1111/j.1530-0277.2012.01900.x · DOI
  61. 10.1002/hep.22734 · DOI
  62. 10.1111/jgh.12116 · DOI
  63. 10.1016/j.cgh.2009.01.001 · DOI
  64. 10.1016/j.dld.2011.05.002 · DOI
  65. Trevisani F, Cantarini MC, Labate AM, De Notariis S, Rapaccini G, Farinati F, Del Poggio P, Di Nolfo MA, Benvegnù L, Zoli M. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival. Am J Gastroenterol 2004;99:1470-1476. · DOI
  66. 10.3748/wjg.v19.i46.8459 · DOI
  67. 10.1016/j.arcmed.2011.08.004 · DOI
  68. 10.3748/wjg.v17.i33.3785 · DOI
  69. 10.1016/j.atherosclerosis.2013.07.052 · DOI
  70. 10.1042/CS20070311 · DOI
  71. Loria P, Lonardo A, Bellentani S, Day CP, Marchesini G, Carulli N. Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question. Nutr Metab Cardiovasc Dis 2007;17:684-698. · DOI
  72. 10.3748/wjg.v20.i7.1724 · DOI
  73. Akahoshi M, Amasaki Y, Soda M, Tominaga T, Ichimaru S, Nakashima E, Seto S, Yano K. Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan. Hypertens Res 2001;24:337-343. · DOI
  74. 10.1210/jc.2011-3010 · DOI
  75. 10.1136/gut.2011.237974 · DOI
  76. Floreani A. Liver diseases in the elderly: an update. Dig Dis 2007;25:138-143. · DOI
  77. 10.1093/ageing/afn242 · DOI
  78. Marchesini G, Bua V, Brunori A, Bianchi G, Pisi P, Fabbri A, Zoli M, Pisi E. Galactose elimination capacity and liver volume in aging man. Hepatology 1988;8:1079-1083. · DOI
  79. Attili AF, Capocaccia R, Carulli N, Festi D, Roda E, Barbara L, Capocaccia L, Menotti A, Okolicsanyi L, Ricci G. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology 1997;26:809-818. · DOI
  80. Ericsson S, Eriksson M, Vitols S, Einarsson K, Berglund L, Angelin B. Influence of age on the metabolism of plasma low density lipoproteins in healthy males. J Clin Invest 1991;87:591-596. · DOI
  81. Einarsson K, Nilsell K, Leijd B, Angelin B. Influence of age on secretion of cholesterol and synthesis of bile acids by the liver. N Engl J Med 1985;313:277-282. · DOI
  82. Bertolotti M, Abate N, Bertolotti S, Loria P, Concari M, Messora R, Carubbi F, Pinetti A, Carulli N. Effect of aging on cholesterol 7 alpha-hydroxylation in humans. J Lipid Res 1993;34:1001-1007. · DOI
  83. 10.2147/CIA.S57714 · DOI
  84. 10.1111/acel.12128 · DOI
  85. 10.1016/j.tem.2008.08.005 · DOI
  86. Utzschneider KM, Kahn SE. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2006;91:4753-4761. · DOI
  87. 10.1586/eem.10.5 · DOI
  88. 10.1093/gerona/gls145 · DOI
  89. Ceda GP, Dall’Aglio E, Magnacavallo A, Vargas N, Fontana V, Maggio M, Valenti G, Lee PD, Hintz RL, Hoffman AR. The insulin-like growth factor axis and plasma lipid levels in the elderly. J Clin Endocrinol Metab 1998;83:499-502.
  90. Paolisso G, Tagliamonte MR, Rizzo MR, Giugliano D. Advancing age and insulin resistance: new facts about an ancient history. Eur J Clin Invest 1999;29:758-769. · DOI
  91. Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Ble A, Egan J, Paolisso G, Najjar S, Jeffrey Metter E. Association between hormones and metabolic syndrome in older Italian men. J Am Geriatr Soc 2006;54:1832-1838. · DOI
  92. Bertolotti M, Gabbi C, Anzivino C, Crestani M, Mitro N, Del Puppo M, Godio C, De Fabiani E, Macchioni D, Carulli L. Age-related changes in bile acid synthesis and hepatic nuclear receptor expression. Eur J Clin Invest 2007;37:501-508. · DOI
  93. 10.1210/jc.2011-1227 · DOI · Paper page
  94. 10.1038/nrgastro.2009.33 · DOI
  95. 10.3748/wjg.v19.i40.6735 · DOI
  96. 10.1053/j.gastro.2013.11.049.[Epub · DOI
  97. 10.1038/sj.bjp.0706260 · DOI
  98. 10.1093/gerona/glr124 · DOI
  99. Masetti M, Bianchi G, Gianotti G, Giovagnoli M, Vizioli L, Zorzi V, Rossi V, Forti P, Zoli M. Adipocyte-fatty acid binding protein and non-alcoholic fatty liver disease in the elderly. Aging Clin Exp Res 2014;26:241-247. · DOI
  100. Fontana L, Zhao E, Amir M, Dong H, Tanaka K, Czaja MJ. Aging promotes the development of diet-induced murine steatohepatitis but not steatosis. Hepatology 2013;57:995-1004. · DOI
  101. Salvioli S, Monti D, Lanzarini C, Conte M, Pirazzini C, Bacalini MG, Garagnani P, Giuliani C, Fontanesi E, Ostan R. Immune system, cell senescence, aging and longevity--inflamm-aging reappraised. Curr Pharm Des 2013;19:1675-1679.
  102. Tarantino G, Savastano S, Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol 2010;16:4773-4783. · DOI
  103. 10.1186/1479-5876-9-136 · DOI
  104. Panasiuk A, Dzieciol J, Panasiuk B, Prokopowicz D. Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease. World J Gastroenterol 2006;12:6198-6202. · DOI
  105. 10.1016/j.jhep.2010.06.021 · DOI
  106. 10.3748/wjg.v17.i48.5280 · DOI
  107. 10.1038/oby.2009.3 · DOI
  108. 10.1093/gerona/glp213 · DOI
  109. Stramaglia G, Greco A, Guglielmi G, De Matthaeis A, Vendemiale GL. Echocardiography and dual-energy x-ray absorptiometry in the elderly patients with metabolic syndrome: a comparison of two different tecniques to evaluate visceral fat distribution. J Nutr Health Aging 2010;14:6-10. · DOI
  110. Bertrand HA, Lynd FT, Masoro EJ, Yu BP. Changes in adipose mass and cellularity through the adult life of rats fed ad libitum or a life-prolonging restricted diet. J Gerontol 1980;35:827-835. · DOI · Paper page
  111. 10.1111/j.1474-9726.2010.00608.x · DOI · Paper page
  112. 10.1586/14779072.6.3.343 · DOI
  113. Guo W, Pirtskhalava T, Tchkonia T, Xie W, Thomou T, Han J, Wang T, Wong S, Cartwright A, Hegardt FG. Aging results in paradoxical susceptibility of fat cell progenitors to lipotoxicity. Am J Physiol Endocrinol Metab 2007;292:E1041-E1051. · DOI
  114. 10.1111/j.1440-1746.2008.05733.x · DOI
  115. Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M, Yuan X, Mizuarai S, Kotani H, Yamaoka S, Miyake K, Aoe S. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007;27:84-91. · DOI
  116. Tang QQ, Zhang JW, Daniel Lane M. Sequential gene promoter interactions of C/EBPbeta, C/EBPalpha, and PPARgamma during adipogenesis. Biochem Biophys Res Commun 2004;319:235-239. · DOI
  117. 10.1016/j.febslet.2010.06.010 · DOI
  118. 10.1016/j.bbadis.2012.03.014 · DOI
  119. Gerin I, Dolinsky VW, Shackman JG, Kennedy RT, Chiang SH, Burant CF, Steffensen KR, Gustafsson JA, MacDougald OA. LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. J Biol Chem 2005;280:23024-23031. · DOI
  120. 10.1016/j.arr.2013.05.007 · DOI
  121. 10.1093/dnares/dsn033 · DOI
  122. Moore WE, Holdeman LV. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol 1974;27:961-979. · DOI · Paper page
  123. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 2007;449:804-810. · DOI · Paper page
  124. 10.1038/nature12251 · DOI
  125. Bauer E, Williams BA, Smidt H, Verstegen MW, Mosenthin R. Influence of the gastrointestinal microbiota on development of the immune system in young animals. Curr Issues Intest Microbiol 2006;7:35-51.
  126. Rolfe RD. Colonization resistance. Gastrointestinal Microbiolog. London: Chapman and Hall; 1997;501-536. · DOI
  127. Cummings JH, Macfarlane GT. Role of intestinal bacteria in nutrient metabolism. JPEN J Parenter Enteral Nutr 1997;21:357-365. · DOI
  128. Deguchi Y, Morishita T, Mutai M. Comparative studies on synthesis of water-soluble vitamins among human species of bifidobacteria. Agric Biol Chem 1985;49:13-19.
  129. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007;104:13780-13785. · DOI · Paper page
  130. 10.1007/s11357-011-9217-5 · DOI
  131. O’Toole PW, Claesson MJ. Gut microbiota: Changes throughout the lifespan from infancy to elderly. Int Dairy J 2010;20:281-291. · DOI
  132. 10.1038/nature11319 · DOI · Paper page
  133. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, Cresci A, Silvi S, Orpianesi C, Verdenelli MC. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 2006;72:1027-1033. · DOI · Paper page
  134. 10.1007/s11357-008-9081-0 · DOI
  135. 10.1073/pnas.1000097107 · DOI · Paper page
  136. 10.1007/82_2011_189 · DOI
  137. 10.1016/j.immuni.2009.08.012 · DOI
  138. Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005;307:1920-1925. · DOI
  139. 10.1152/physiol.00040.2007 · DOI
  140. 10.1126/science.1208344 · DOI · Paper page
  141. 10.1038/nature11552 · DOI · Paper page
  142. Boyce JM, Shone GR. Effects of ageing on smell and taste. Postgrad Med J 2006;82:239-241. · DOI
  143. Gupta A, Epstein JB, Sroussi H. Hyposalivation in elderly patients. J Can Dent Assoc 2006;72:841-846.
  144. Laurin D, Brodeur JM, Bourdages J, Vallée R, Lachapelle D. Fibre intake in elderly individuals with poor masticatory performance. J Can Dent Assoc 1994;60:443-446, 449.
  145. Elphick HL, Elphick DA, Sanders DS. Small bowel bacterial overgrowth. An underrecognized cause of malnutrition in older adults. Geriatrics 2006;61:21-26.
  146. 10.1017/S0007114509338842 · DOI
  147. 10.1016/j.jsbmb.2010.05.008 · DOI
  148. 10.1093/qjmed/hcn138 · DOI
  149. de Groot LC, Verheijden MW, de Henauw S, Schroll M, van Staveren WA. Lifestyle, nutritional status, health, and mortality in elderly people across Europe: a review of the longitudinal results of the SENECA study. J Gerontol A Biol Sci Med Sci 2004;59:1277-1284. · DOI
  150. Kenney WL, Chiu P. Influence of age on thirst and fluid intake. Med Sci Sports Exerc 2001;33:1524-1532. · DOI
  151. 10.1152/ajpgi.00048.2011 · DOI
  152. 10.1053/j.gastro.2009.01.075 · DOI · Paper page
  153. 10.1159/000115345 · DOI
  154. Karlström O, Fryklund B, Tullus K, Burman LG. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis 1998;26:141-145.
  155. 10.1017/S0007114509991553 · DOI
  156. Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 2001;182:11S-18S. · DOI
  157. 10.1007/s00535-009-0147-2 · DOI
  158. Abbatecola AM, Paolisso G, Fattoretti P, Evans WJ, Fiore V, Dicioccio L, Lattanzio F. Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction. J Nutr Health Aging 2011;15:890-895. · DOI · Paper page
  159. Sinha R, Dufour S, Petersen KF, LeBon V, Enoksson S, Ma YZ, Savoye M, Rothman DL, Shulman GI, Caprio S. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 2002;51:1022-1027. · DOI
  160. 10.1038/ejcn.2012.43 · DOI
  161. Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003;88:5766-5772. · DOI
  162. 10.1186/1741-7015-9-85 · DOI
  163. 10.1002/hep.24737 · DOI
  164. 10.1007/s10620-013-2658-1 · DOI
  165. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, Taylor-Robinson SD. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002;35:433-439. · DOI
  166. 10.1002/hep.22752 · DOI
  167. Brea A, Mosquera D, Martín E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study. Arterioscler Thromb Vasc Biol 2005;25:1045-1050. · DOI
  168. 10.1001/archinte.167.19.2145-b · DOI
  169. 10.1017/S0007114512004175 · DOI · Paper page
  170. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell’Orto S, Piccaluga E. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986;59:178-193. · DOI · Paper page
  171. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996;93:1043-1065. · DOI · Paper page
  172. 10.1371/journal.pone.0061803 · DOI
  173. Guzzetti S, Borroni E, Garbelli PE, Ceriani E, Della Bella P, Montano N, Cogliati C, Somers VK, Malliani A, Porta A. Symbolic dynamics of heart rate variability: a probe to investigate cardiac autonomic modulation. Circulation 2005;112:465-470. · DOI
  174. 10.1111/j.1478-3231.2009.01985.x · DOI
  175. 10.1159/000282089 · DOI
  176. 10.1007/s10286-009-0031-4 · DOI
  177. 10.1042/CS20120684 · DOI
  178. 10.1016/S0140-6736(11)61514-6 · DOI
  179. 10.1371/journal.pone.0057183 · DOI
  180. 10.1161/CIRCULATIONAHA.110.955542 · DOI
  181. 10.1055/s-0029-1222606 · DOI
  182. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104:2886-2891. · DOI
  183. 10.1186/1475-2891-12-37 · DOI
  184. 10.1016/j.cld.2013.09.005 · DOI
  185. 10.1016/j.clinre.2012.10.009 · DOI
  186. 10.3945/ajcn.111.020156 · DOI
  187. 10.1093/annonc/mdt168 · DOI
  188. 10.1053/j.gastro.2012.02.018 · DOI
  189. 10.1007/s11894-012-0299-8 · DOI
  190. 10.1016/j.cger.2012.01.002 · DOI
  191. Tarantino G, Conca P, Basile V, Gentile A, Capone D, Polichetti G, Leo E. A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. Hepatol Res 2007;37:410-415. · DOI · Paper page
  192. Premoli A, Paschetta E, Hvalryg M, Spandre M, Bo S, Durazzo M. Characteristics of liver diseases in the elderly: a review. Minerva Gastroenterol Dietol 2009;55:71-78.
  193. Estep JM, Birerdinc A, Younossi Z. Non-invasive diagnostic tests for non-alcoholic fatty liver disease. Curr Mol Med 2010;10:166-172. · DOI
  194. Corey KE, Chalasani N. Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2014;12:1077-1084; quiz e59-e60. · DOI
  195. Chalasani N. Statins and hepatotoxicity: focus on patients with fatty liver. Hepatology 2005;41:690-695. · DOI
  196. 10.1002/hep.22402 · DOI
  197. 10.1016/j.dld.2010.01.021 · DOI
  198. 10.1016/S0140-6736(10)61272-X · DOI · Paper page
  199. 10.1016/j.dld.2012.02.020 · DOI
  200. 10.1053/j.gastro.2009.01.043 · DOI

200 of 222 shown

Cited by

Sorted by citations

Metadata

Authors
Bertolotti, M.
Venue
World Journal of Gastroenterology
Publisher
Baishideng Publishing Group Inc.
Published
2014
Volume
20
Issue
39
Pages
14185
ISSN
1007-9327
DOI
10.3748/wjg.v20.i39.14185
Cited by
270
References
28
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review